Related Experiment Video
Updated: Aug 19, 2026

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice
Published on: February 3, 2012
[Acute cholestatic hepatitis induced by dextromethorphan]
C de la Serna Higuera1, S J Rodríguez Gómez, A Pérez Villoria
1Unidad de Digestivo, Servicio de Medicina Interna, Hospital Virgen de la Concha, Zamora.
Abstract:
A case of a 68-years-old female who was symptomatically treated with the codeine analog dextromethorphan because of a flu-like syndrome is herein reported. Five days later, she developed a cholestatic syndrome without fever or abdominal pain. Dextrometorphan was withdrawn and a rapid clinical improvement was observed, associated with decreasing levels of biochemical markers of cholestasis. Normal values were reached two months later. This type of adverse drug reaction, its potential pathogenic mechanisms and the therapeutic consequences are discussed.
Related Concept Videos
Direct-Acting Cholinergic Agonists: Pharmacokinetics
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by anesthetizing...
Hepatic Drug Excretion: Influencing Factors
Toxidromes: Clinical Features
Hepatitis
Cholecystitis

